- Home
- INBX vs ISPR Comparison
INBX vs ISPR Comparison
Compare INBX & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- ISPR
- Stock Information
- Founded
- INBX 2010
- ISPR 2019
- Country
- INBX United States
- ISPR United States
- Employees
- INBX N/A
- ISPR N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- ISPR Medicinal Chemicals and Botanical Products
- Sector
- INBX Health Care
- ISPR Health Care
- Exchange
- INBX Nasdaq
- ISPR Nasdaq
- Market Cap
- INBX 178.5M
- ISPR 152.0M
- IPO Year
- INBX 2020
- ISPR 2023
- Fundamental
- Price
- INBX $21.73
- ISPR $2.92
- Analyst Decision
- INBX Hold
- ISPR Strong Buy
- Analyst Count
- INBX 1
- ISPR 2
- Target Price
- INBX N/A
- ISPR $10.00
- AVG Volume (30 Days)
- INBX 122.5K
- ISPR 100.1K
- Earning Date
- INBX 08-12-2025
- ISPR 09-10-2025
- Dividend Yield
- INBX N/A
- ISPR N/A
- EPS Growth
- INBX N/A
- ISPR N/A
- EPS
- INBX 111.58
- ISPR N/A
- Revenue
- INBX $200,000.00
- ISPR $144,700,345.00
- Revenue This Year
- INBX N/A
- ISPR N/A
- Revenue Next Year
- INBX N/A
- ISPR $35.39
- P/E Ratio
- INBX $0.20
- ISPR N/A
- Revenue Growth
- INBX N/A
- ISPR N/A
- 52 Week Low
- INBX $10.80
- ISPR $2.09
- 52 Week High
- INBX $22.31
- ISPR $7.93
- Technical
- Relative Strength Index (RSI)
- INBX 84.22
- ISPR 56.89
- Support Level
- INBX $13.97
- ISPR $2.65
- Resistance Level
- INBX $15.25
- ISPR $3.00
- Average True Range (ATR)
- INBX 1.10
- ISPR 0.31
- MACD
- INBX 0.66
- ISPR 0.06
- Stochastic Oscillator
- INBX 95.32
- ISPR 73.28
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.